News | News By Subject | News by Disease News By Date | Search News

Nerve regeneration News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Rejects Pfizer Inc. (PFE)'s Drug for Rare Nerve Disease     6/20/2012
Vanda Pharmaceuticals, Inc. Sets IPO Price At $12-$14 Per Share     3/21/2006
Curis, Inc. (CRIS) And Wyeth (WYE) Extend Nerve Drug Pact     11/21/2005
ExonHit Therapeutics SA Achieves First Research Milestone In Its Collaboration With Allergan Inc. (AGN); Compound Synthesized At ExonHit Demonstrates Promising Preclinical Profile     12/13/2004
Ruxton Pharmaceuticals, Inc. Secures $5.2 Million Series A Financing; Baltimore And National VCs Invest In Neurodegenerative Disease Fight     7/26/2004
MethylGene And EnVivo Pharmaceuticals, Inc. To Collaborate In Neurodegenerative Diseases-EnVivo And MethylGene To Develop Isotypic Selective HDAC Inhibitors To Treat Neurodegenerative Diseases     7/13/2004

News from Around the Web
Experimental Alzheimer's Disease Drugs Might Help Patients with Nerve Injuries, Johns Hopkins University School of Medicine Study     4/14/2011
Antibodies Involved in Nerve Repair in Injuries, Stanford University School of Medicine Researchers Find     6/15/2010
Protein Shown To Play A Key Role In Normal Development Of Nervous System, Children's Hospital of Philadelphia Study     10/17/2008
Nerve Cells Grown from New-Style Stem Cells in Harvard Medical School Study     8/1/2008
UT Southwestern Medical Center Researchers Create Molecule That Nudges Nerve Stem Cells To Mature     6/16/2008
First Evidence Of Native Dendritic Cells In Brain Surprises Scientists, Rockefeller University Study     5/20/2008
Optic Nerve Regeneration Induced In Adult Mice     3/1/2005
Science Inches Closer To Regenerating Sight     2/23/2004

Press Releases
BrainStorm Cell Therapeutics Inc. Announces Clinical Data Supporting Safety and Efficacy of NurOwn™ Based on Initial Patient Results     1/17/2012
BrainStorm Cell Therapeutics Inc.'s Clinical Trials Featured on the Israeli Radio Popular Morning News (Yoman Haboker)     11/11/2011
Children's Hospital Boston Release: New Approaches Open up in Spinal Muscular Atrophy     6/6/2011
FibroGen, Inc. Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration     8/25/2010
Newron Pharmaceuticals Announces Positive Results From Preclinical Study     9/14/2006
Mary Ann Liebert, Inc. Release: New Findings Support Promise Of Using Stem Cells To Treat Neurodegenerative Diseases     5/1/2006
Cyberkinetics Inc. (CYKN)'s Andara(TM) Combination Product Yields Nerve Regeneration And Functional Recovery In Model for Chronic Spinal Cord Injury     4/25/2006
CepTor Corporation (CEPO.OB) Announces Patent Filing For Neurodur (C-201) Pro-Drug In Multiple Sclerosis And Other Neurodegenerative Diseases     9/30/2005
CepTor Corporation's (CEPO.OB) Drug Development Initiatives Substantiated By New England Journal Of Medicine Article; Article Implicates Calpain In Duchenne Muscular Dystrophy And Other Neuromuscular And Neurodegenerative Diseases     6/22/2005
Ablynx And The National Research Council of Canada Sign Collaborative Deal To Develop Nanobodies For CNS Disorders     5/26/2005
Neuren Pharmaceuticals Limited And Metabolic Pharmaceuticals (MBP.AX) Collaborate To Develop Range Of Nerve Repair Compounds With Support From New Zealand Government     3/7/2005
Proneuron Biotechnologies, Inc. (US Branch) Announces Milestone Patent For Copolymer-1 -- Cop-1; Patent Expands Use Of Cop-1, Previously Approved For The Treatment Of MS     2/15/2005
Alnylam Pharmaceuticals (ALNY) Initiates Program To Develop RNAi Therapeutics For Spinal Cord Injury     1/25/2005
Synovis Life Technologies (SYNO) Acquires The Neurotube(R) Nerve Conduit     12/7/2004
CytRx Corporation (CYTR) Announces Scientific Data Showing The Potential Of Its Oral Drug, Arimoclomol, To Reverse Nerve Degeneration     12/6/2004

//-->